Clinical Trials · NCT02973100
A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 318
- Start date
- Dec 2016
- Locations
- 66 sites, 6 countries
- Primary endpoint
- Change From Baseline in Hemoglobin A1c (HbA1c)